Custom Gene Expression Profiling of Circulating Tumor Cells via Amplitude-Based Multiplex digital PCR
The value of characterising Circulating Tumour Cells using Epithelial and Mesenchymal markers in Breast Cancer
Complementary detection strategies for circulating tumor cells in breast cancer: clinical implications of combining immunofluorescence and cytopathological staining
Phylogenetic inference reveals clonal heterogeneity in circulating tumour cell clusters
Mechanical Conditioning (MeCo) Score Progressively Increases Through the Metastatic Cascade in Breast Cancer via Circulating Tumour Cells
Analytical validation of ANGLE’s combined IF and FISH assay for assessment of HER2 in circulating tumor cells
DDRi Summit 2025: Monitoring of DNA Damage Response Biomarkers using Circulating Tumour Cells captured with ANGLE’s Parsortix® instrument from Ovarian, Prostate, and Breast cancer patients
Digoxin for reduction of circulating tumour cell cluster size in metastatic breast cancer
SABCS: A novel, semi-automated Pipeline for HER2 Quantification on CTCs in breast cancer patients. Is cytopathology of peripheral blood a new diagnostic option?
AACR LBx 24 – Development of a scoring system to classify HER2 protein expression in Circulating Tumour Cells through immunofluorescence following isolation using Parsortix® instruments